Forte Biosciences Inc reports results for the quarter ended in March - Earnings Summary

Forte Biosciences

11/05/2021 24:27

* Forte Biosciences Inc  FBRX.OQ  reported a quarterly adjusted
loss of 36 cents​​ per share for the quarter ended in March. The
mean expectation of three analysts for the quarter was for a
loss of 52 cents per share.
* Revenue was $0.00​​;  analysts expected $0.00.
* Forte Biosciences Inc's reported EPS for the quarter was a
loss of 36 cents​.
* The mean earnings estimate of analysts had risen by about 0.9%
in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Forte Biosciences Inc shares had fallen by 4.8% this
quarter and lost 10.4% so far this year.
* The company reported a quarterly loss of $4.8 million.
* Wall Street's median 12-month price target for Forte
Biosciences Inc is $90.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated May 10 at 11:27 p.m. GMT.
​All figures in $